Expiration date: 05/2025
Form of issue:
Spray nasal dose
spray nasal dose 11.25 mg/dose vial (bottle) with the plastic dosing device 10 ml pack carton 1
spray nasal dose 22.5 mcg/dose vial (bottle) with the plastic dosing device 10 ml pack carton 1
Pharmacological action:
Adrenomimeticescoe tool for local use. Has a vasoconstrictor effect. In intra reduces swelling of mucous membrane upper divisions respiratory tract. With instillation into the conjunctival SAC reduces the swelling of the conjunctiva.
Pharmacokinetics
The expression 15 minutes after application and lasts for 6-8 hours.
Indications:
Difficulty in nasal breathing with colds, inflammation of the sinuses, Eustachian, hay fever, allergic rhinitis, congestion and swelling of the conjunctiva.
Dosing regimen:
Use local.
Side effects
The respiratory system: possible transient dryness and burning sensation of the mucosa of the nasal passages, dry mouth and throat, sneezing, prolonged use may cause reactive hyperemia of the mucosa, atrophy of the mucous membrane.
From the side of cardiovascular system: palpitations, rarely - arterial hypertension.
CNS: anxiety, dizziness, headache, sleep disturbance, long-term use - tachyphylaxis.
From the digestive system: nausea.
On the part of the organ of vision: while the introduction of possible conjunctival mydriasis, paresis of accommodation, irritation of the conjunctiva and surrounding tissue, retraction century.
Contraindications:
Inflammation of the lining of the nasal passages without secretions, congestive heart failure, hyperthyroidism, diabetes mellitus, pregnancy, children up to age 6 years (for eye drops), hypersensitivity to Oxymetazoline, atrophic rhinitis, lactation, arrhythmias, marked atherosclerosis, arterial hypertension, chronic renal failure, angle-closure glaucoma.
Application of pregnancy and breastfeeding
Oxymetazoline is contraindicated during pregnancy and lactation (breastfeeding).
Special instructions:
In the recommended dosage without consulting a doctor can be used not more than 3 days. To avoid drug intended for intranasal administration in the eye.
Effects on ability to drive vehicles and management mechanisms
The drug has an effect on vision, the decline in the rate of the reaction.
Drug interactions
In case of simultaneous appointment of MAO inhibitors and tricyclic antidepressants can raise AD.
Oxymetazoline slows down the absorption of local anaesthetic drugs, extends the effect.
Joint appointment other vasoconstrictor drugs increases the risk of side effects.
Storage conditions:
The temperature is not above 25*C
Expiration date:
3 years.
